Indian Company Master Data Made Simple
Search:
MCA
GSTIN
LEI
Udyam
Directors
36+ lakh companies in our registry
Alembic Pharmaceuticals Limited
Incorporated on 15 Jun 2010, Alembic Pharmaceuticals Limited has been operating for 16 years. Alembic Pharmaceuticals Limited holds the CIN L24230GJ2010PLC061123 and registration number 61123. The company is classified as company limited by shares. The company has an authorized share capital of ₹40.50 crore. Its paid up capital is ₹39.31 crore.
The firm focuses on manufacture of other chemical products. The company has been registered in the city of Ahmedabad. It is incorporated at Alembic Road, Vadodara, Vadodara, Gujarat, India, 390003. The entity is active and conducting operations. According to official records, the company’s PAN is AAICA5591M. Its LEI code is registered as 335800PM173KNG818V30. Alembic Pharmaceuticals Limited can be contacted at apl.investors@alembic.co.in. Key executives of the company are: Chirayu Ramanbhai Amin (CEO) and Rajkumar Shreeram Baheti (CFO).
Company Overview
- CIN
- Date of Incorporation
- 15/06/2010
- Company Status
- Active
- RoC
- Ahmedabad
- Registration Number
- Balance sheet date
- 31/03/2024
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- LEI Status
- Issued
- Authorized Capital
- ₹40,50,00,000.00
- Paid up Capital
- ₹39,31,26,248.00
- Activity
- Manufacture of other chemical products
- apl.investors@alembic.co.in
- PAN
GST Numbers
| State | GST Number | Status |
|---|---|---|
| Assam | 18AAICA5591M2Z1 | Inactive |
| 18AAICA5591M1Z2 | Active | |
| Andhra Pradesh | 37AAICA5591M1Z2 | Active |
| Bihar | 10AAICA5591M1ZI | Active |
| Chandigarh | 04AAICA5591M1ZB | Inactive |
| Chhattisgarh | 22AAICA5591M1ZD | Active |
| Delhi | 07AAICA5591M1Z5 | Active |
| Gujarat | 24AAICA5591M1Z9 | Active |
| 24AAICA5591M2Z8 | Active | |
| Haryana | 06AAICA5591M1Z7 | Active |
ISIN Numbers
| ISIN | Security | Interest Rate | Maturity Date | FISN | CFI |
|---|---|---|---|---|---|
| INE901L14CS9 | ALEMBIC PHARMACEUTICALS LIMITED 90D CP 16DEC26 | - | 16/12/2026 | ALEMBIC PHARMA/CP 20261216 | DYZUXN |
| INE901L14CQ3 | ALEMBIC PHARMACEUTICALS LIMITED 91D CP 11DEC26 | - | 11/12/2026 | ALEMBIC PHARMA/CP 20261211 | DYZUXN |
| INE901L14CR1 | ALEMBIC PHARMACEUTICALS LIMITED 91D CP 10DEC26 | - | 10/12/2026 | ALEMBIC PHARMA/CP 20261210 | DYZUXN |
| INE901L14CT7 | ALEMBIC PHARMACEUTICALS LIMITED 58D CP 04DEC26 | - | 04/12/2026 | ALEMBIC PHARMA/CP 20261204 | DYZUXN |
| INE901L14CP5 | ALEMBIC PHARMACEUTICALS LIMITED 91D CP 03DEC26 | - | 03/12/2026 | ALEMBIC PHARMA/CP 20261203 | DYZUXN |
| IN8901L01017 | ALEMBIC PHARMACEUTICALS LIMITED EQ LISTING/TRADING APPROVAL AWAITED | - | 12/10/2026 | ALEMBIC PHARMA/SH VTG | ESVUFN |
| INE901L01018 | ALEMBIC PHARMACEUTICALS LIMITED EQ | - | 12/10/2026 | ALEMBIC PHARMA/SH VTG | ESVUFN |
Balance Sheet
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Net PPE | ₹3,49,272.00L | ₹3,39,191.00L | ₹3,07,105.00L | ₹2,99,973.00L | ₹0.00L |
| Net Debt | ₹1,16,448.00L | ₹1,11,209.00L | ₹31,024.00L | ₹56,038.00L | ₹0.00L |
| Gross PPE | ₹5,30,151.00L | ₹4,98,570.00L | ₹4,39,955.00L | ₹4,06,878.00L | ₹0.00L |
| Inventory | ₹2,51,064.00L | ₹2,28,814.00L | ₹1,64,354.00L | ₹1,47,527.00L | ₹0.00L |
| Total Debt | ₹1,42,994.00L | ₹1,25,750.00L | ₹51,316.00L | ₹72,201.00L | ₹0.00L |
| Common Stock | ₹3,931.00L | ₹3,931.00L | ₹3,931.00L | ₹3,931.00L | ₹0.00L |
| Current Debt | ₹1,23,893.00L | ₹1,19,557.00L | ₹43,045.00L | ₹63,586.00L | ₹0.00L |
| Share Issued | ₹1,965.63L | ₹1,965.63L | ₹1,965.63L | ₹1,965.63L | ₹0.00L |
| Total Assets | ₹8,76,259.00L | ₹7,77,294.00L | ₹6,44,558.00L | ₹6,18,283.00L | ₹0.00L |
| Capital Stock | ₹3,931.00L | ₹3,931.00L | ₹3,931.00L | ₹3,931.00L | ₹0.00L |
| Long Term Debt | ₹12,192.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Current Assets | ₹4,54,259.00L | ₹4,08,779.00L | ₹3,07,856.00L | ₹2,91,002.00L | ₹0.00L |
| Prepaid Assets | ₹35,227.00L | ₹29,877.00L | ₹23,277.00L | ₹22,337.00L | ₹0.00L |
| Working Capital | ₹1,94,876.00L | ₹1,67,545.00L | ₹1,62,356.00L | ₹1,27,310.00L | ₹0.00L |
| Invested Capital | ₹7,03,566.00L | ₹6,38,651.00L | ₹5,24,865.00L | ₹5,00,632.00L | ₹0.00L |
| Other Properties | ₹45,120.00L | ₹44,507.00L | ₹43,722.00L | ₹43,423.00L | ₹0.00L |
| Retained Earnings | ₹4,85,408.00L | ₹4,39,422.00L | ₹4,02,701.00L | ₹3,56,844.00L | ₹0.00L |
| Common Stock Equity | ₹5,67,481.00L | ₹5,19,094.00L | ₹4,81,820.00L | ₹4,37,046.00L | ₹0.00L |
| Net Tangible Assets | ₹5,38,804.00L | ₹5,19,094.00L | ₹4,81,820.00L | ₹4,37,046.00L | ₹0.00L |
| Tangible Book Value | ₹5,38,804.00L | ₹5,19,094.00L | ₹4,81,820.00L | ₹4,37,046.00L | ₹0.00L |
| Current Liabilities | ₹2,59,383.00L | ₹2,41,234.00L | ₹1,45,500.00L | ₹1,63,692.00L | ₹0.00L |
| Long Term Provisions | ₹15,291.00L | ₹12,431.00L | ₹10,951.00L | ₹10,620.00L | ₹0.00L |
| Stockholders Equity | ₹5,67,481.00L | ₹5,19,094.00L | ₹4,81,820.00L | ₹4,37,046.00L | ₹0.00L |
| Other Equity Interest | ₹5,63,550.00L | ₹5,15,163.00L | ₹1.00L | ₹4,33,116.00L | ₹0.00L |
| Total Capitalization | ₹5,79,673.00L | ₹5,19,094.00L | ₹4,81,820.00L | ₹4,37,046.00L | ₹0.00L |
| Ordinary Shares Number | ₹1,965.63L | ₹1,965.63L | ₹1,965.63L | ₹1,965.63L | ₹0.00L |
| Other Intangible Assets | ₹28,677.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹15,482.00L |
| Other Non Current Assets | ₹1.00L | -₹1.00L | ₹3,330.00L | ₹5,374.00L | ₹0.00L |
| Total Non Current Assets | ₹4,18,999.00L | ₹3,68,514.00L | ₹3,36,702.00L | ₹3,27,281.00L | ₹0.00L |
| Cash And Cash Equivalents | ₹19,637.00L | ₹8,348.00L | ₹12,021.00L | ₹7,548.00L | ₹0.00L |
| Construction In Progress | ₹64,913.00L | ₹86,838.00L | ₹52,436.00L | ₹60,128.00L | ₹0.00L |
| Accumulated Depreciation | -₹1,80,879.00L | -₹1,59,379.00L | -₹1,32,850.00L | -₹1,06,905.00L | ₹0.00L |
| Additional Paid In Capital | ₹74,839.00L | ₹74,839.00L | ₹74,839.00L | ₹74,839.00L | ₹0.00L |
| Other Short Term Investments | ₹2,022.00L | ₹1,815.00L | ₹2,713.00L | ₹1,664.00L | ₹0.00L |
| Other Non Current Liabilities | ₹18,019.00L | ₹1,892.00L | -₹1.00L | ₹2.00L | ₹0.00L |
| Machinery Furniture Equipment | ₹3,08,947.00L | ₹2,61,952.00L | ₹2,41,146.00L | ₹2,06,183.00L | ₹0.00L |
| Goodwill And Other Intangible Assets | ₹28,677.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹5,66,898.00L | ₹5,18,952.00L | ₹4,81,820.00L | ₹4,37,046.00L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹3,09,361.00L | ₹2,58,342.00L | ₹1,62,738.00L | ₹1,81,237.00L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹1,26,326.00L | ₹1,21,073.00L | ₹45,028.00L | ₹65,278.00L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹16,668.00L | ₹4,677.00L | ₹6,288.00L | ₹6,923.00L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹19,637.00L | ₹8,348.00L | ₹12,021.00L | ₹7,548.00L | ₹0.00L |
| Total Non Current Liabilities Net Minority Interest | ₹49,978.00L | ₹17,108.00L | ₹17,238.00L | ₹17,545.00L | ₹0.00L |
Cash Flow
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Net Income | ₹67,477.00L | ₹58,342.00L | ₹61,582.00L | ₹34,199.00L | ₹0.00L |
| Free Cash Flow | ₹28,785.00L | -₹47,565.00L | ₹47,573.00L | ₹28,054.00L | ₹0.00L |
| Changes In Cash | ₹11,288.00L | -₹3,673.00L | ₹4,472.00L | ₹1,440.00L | ₹0.00L |
| End Cash Position | ₹19,637.00L | ₹8,348.00L | ₹12,021.00L | ₹7,548.00L | ₹0.00L |
| Financing Cash Flow | -₹16,379.00L | ₹44,371.00L | -₹43,787.00L | -₹26,196.00L | ₹0.00L |
| Investing Cash Flow | -₹50,606.00L | -₹56,841.00L | -₹32,061.00L | -₹44,759.00L | ₹0.00L |
| Operating Cash Flow | ₹78,273.00L | ₹8,797.00L | ₹80,320.00L | ₹72,395.00L | ₹0.00L |
| Capital Expenditure | -₹49,488.00L | -₹56,362.00L | -₹32,747.00L | -₹44,341.00L | ₹0.00L |
| Beginning Cash Position | ₹8,348.00L | ₹12,021.00L | ₹7,548.00L | ₹6,109.00L | ₹0.00L |
| Other Cash Adjustment Outside Changein Cash | ₹1.00L | ₹0.00L | ₹1.00L | -₹1.00L | ₹0.00L |
Income Statement
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 |
|---|---|---|---|---|
| EBIT | ₹78,758.00L | ₹78,595.00L | ₹68,802.00L | ₹40,476.00L |
| Ebit | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| EBITDA | ₹1,10,613.00L | ₹1,06,453.00L | ₹96,069.00L | ₹68,019.00L |
| Basic EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income | ₹67,477.00L | ₹58,342.00L | ₹61,582.00L | ₹34,199.00L |
| Diluted EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Gross Profit | ₹4,85,287.00L | ₹4,40,280.00L | ₹4,11,141.00L | ₹3,47,661.00L |
| Pretax Income | ₹69,395.00L | ₹70,718.00L | ₹63,183.00L | ₹35,459.00L |
| Tax Provision | ₹2,312.00L | ₹12,517.00L | ₹1,600.00L | ₹1,261.00L |
| Total Revenue | ₹7,21,261.00L | ₹6,53,971.00L | ₹6,11,211.00L | ₹5,49,977.00L |
| Cost Of Revenue | ₹2,35,974.00L | ₹2,13,691.00L | ₹2,00,070.00L | ₹2,02,316.00L |
| Total Expenses | ₹6,40,869.00L | ₹5,80,467.00L | ₹5,44,857.00L | ₹5,05,569.00L |
| Interest Income | ₹86.00L | ₹596.00L | ₹209.00L | ₹33.00L |
| Interest Expense | ₹9,363.00L | ₹7,877.00L | ₹5,619.00L | ₹5,017.00L |
| Operating Income | ₹80,392.00L | ₹73,504.00L | ₹66,354.00L | ₹44,408.00L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Income Tax Expense | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Normalized EBITDA | ₹1,17,420.00L | ₹1,05,174.00L | ₹95,548.00L | ₹68,911.00L |
| Normalized Income | ₹74,057.21L | ₹57,289.38L | ₹61,074.19L | ₹35,059.28L |
| Operating Expense | ₹4,04,895.00L | ₹3,66,776.00L | ₹3,44,787.00L | ₹3,03,253.00L |
| Operating Revenue | ₹7,21,261.00L | ₹6,53,971.00L | ₹6,11,211.00L | ₹5,49,977.00L |
| Net Interest Income | -₹9,277.00L | -₹7,281.00L | -₹5,410.00L | -₹4,984.00L |
| Total Unusual Items | -₹6,807.00L | ₹1,279.00L | ₹521.00L | -₹892.00L |
| Basic Average Shares | ₹1,965.63L | ₹1,965.63L | ₹1,965.63L | ₹1,965.63L |
| Diluted Average Shares | ₹1,965.63L | ₹1,965.63L | ₹1,965.63L | ₹1,965.63L |
| Other Operating Expenses | ₹68,116.00L | ₹60,429.00L | ₹57,559.00L | ₹51,840.00L |
| Reconciled Depreciation | ₹31,855.00L | ₹27,858.00L | ₹27,267.00L | ₹27,543.00L |
| Total Operating Expenses | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Reconciled Cost Of Revenue | ₹2,35,974.00L | ₹2,13,691.00L | ₹2,00,070.00L | ₹2,02,316.00L |
| Tax Effect Of Unusual Items | -₹226.79L | ₹226.38L | ₹13.19L | -₹31.72L |
| Interest Income Non Operating | ₹86.00L | ₹596.00L | ₹209.00L | ₹33.00L |
| Selling And Marketing Expense | ₹1,08,311.00L | ₹1,06,486.00L | ₹99,688.00L | ₹95,230.00L |
| Interest Expense Non Operating | ₹9,363.00L | ₹7,877.00L | ₹5,619.00L | ₹5,017.00L |
| Net Income Common Stockholders | ₹67,477.00L | ₹58,342.00L | ₹61,582.00L | ₹34,199.00L |
| Net Income Continuous Operations | ₹67,083.00L | ₹58,201.00L | ₹61,583.00L | ₹34,198.00L |
| Diluted NIAvailto Com Stockholders | ₹67,477.00L | ₹58,342.00L | ₹61,582.00L | ₹34,199.00L |
| General And Administrative Expense | ₹32,866.00L | ₹28,046.00L | ₹25,197.00L | ₹24,105.00L |
| Selling General And Administration | ₹1,41,177.00L | ₹1,34,532.00L | ₹1,24,885.00L | ₹1,19,335.00L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | -₹6,807.00L | ₹1,279.00L | ₹521.00L | -₹892.00L |
| Net Non Operating Interest Income Expense | -₹9,277.00L | -₹7,281.00L | -₹5,410.00L | -₹4,984.00L |
| Net Income Including Noncontrolling Interests | ₹67,083.00L | ₹58,201.00L | ₹61,582.00L | ₹34,199.00L |
| Net Income From Continuing And Discontinued Operation | ₹67,477.00L | ₹58,342.00L | ₹61,582.00L | ₹34,199.00L |
| Net Income From Continuing Operation Net Minority Interest | ₹67,477.00L | ₹58,342.00L | ₹61,582.00L | ₹34,199.00L |
Company Performance (FY23–FY26)
₹7.2 K Cr₹5.4 K Cr₹3.6 K Cr₹1.8 K Cr₹0
FY23FY24FY25FY26
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 16/06/2010 | Chirayu Ramanbhai Amin | 00242549 | Whole-time director | View other directorships |
| 16/06/2010 | Rajkumar Shreeram Baheti | 00332079 | Whole-time director | View other directorships |
| 31/03/2011 | Pranav Chirayu Amin | 00245099 | Managing Director | View other directorships |
| 02/05/2013 | Shaunak Chirayu Amin | 00245523 | Managing Director | View other directorships |
| 28/07/2014 | Rajkumar Shreeram Baheti | *****2161K | CFO | |
| 04/02/2015 | Archana Niranjan Hingorani | 00028037 | Director | View other directorships |
| 27/04/2016 | Chirayu Ramanbhai Amin | *****5729P | CEO | |
| 10/02/2022 | Ashok Kumar Barat | 00492930 | Director | View other directorships |
| 01/04/2023 | Manisha Saraf | *****2967L | Company Secretary | |
| 05/05/2023 | Jai Shishir Diwanji | 00910410 | Director | View other directorships |
| 31/03/2024 | Manish Santoshkumar Kejriwal | 00040055 | Director | View other directorships |
Business Network
CompanyDirectorNot on WeeDooBoard seatKey rolePast seatOwnership
Directors 11
- Shaunak Chirayu AminManaging Director
- Pranav Chirayu AminManaging Director
- Chirayu Ramanbhai AminWhole-time director
- Rajkumar Shreeram BahetiWhole-time director
- Manish Santoshkumar KejriwalDirector
- Jai Shishir DiwanjiDirector
- Ashok Kumar BaratDirector
- Archana Niranjan HingoraniDirector
- Manisha SarafCompany Secretary
- Chirayu Ramanbhai AminCEO
- Rajkumar Shreeram BahetiCFO
Latest Documents
Category:
| Date | Title | Size |
|---|---|---|
| 11/09/2024 | Form MGT-7-31082024 | - |
| 11/09/2024 | Form AOC-4(XBRL)-14082024 | - |
| 28/03/2024 | Form Addendum to AOC-4 CSR-28032024_signed | - |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Dabur India Limited | L24230DL1975PLC007908 | 8/3 Asaf Ali Road, New Delhi, Delhi, India, 110002 |
| Gujchem Distillers India Limited | L24230GJ1939PLC002480 | - |
| Ind Swift Limited | L24230CH1986PLC006897 | 781industrial Area Phase Ii, Chandigarh, Chandigarh, India, 160002 |
| Lyka Labs Limited | L24230GJ1976PLC008738 | 4801/b & 4802/a Gidc Indutrail Estate, Ankleshwar, Gujarat, India, 393002 |
| Torrent Pharmaceuticals Ltd | L24230GJ1972PLC002126 | Torrent Houseoff Ashram Road Navarangpura 9, Ahmedabad, Gujarat, India, 000000 |
Address
Alembic Road, Vadodara, Vadodara, Gujarat, India, 390003
Frequently Asked Questions
What is the incorporation date of Alembic Pharmaceuticals Limited?
The incorporation date of Alembic Pharmaceuticals Limited is 15/06/2010.
What is the authorized share capital and paid-up capital of Alembic Pharmaceuticals Limited?
The authorized share capital of Alembic Pharmaceuticals Limited is ₹40,50,00,000.00. The paid-up capital is ₹39,31,26,248.00.
Who are the current board members & directors of Alembic Pharmaceuticals Limited?
The current board member of Alembic Pharmaceuticals Limited are:
- Archana Niranjan Hingorani
- Chirayu Ramanbhai Amin
- Archana Niranjan Hingorani
- Chirayu Ramanbhai Amin
- Pranav Chirayu Amin
- Shaunak Chirayu Amin
- Rajkumar Shreeram Baheti
- Ashok Kumar Barat
- Manish Santoshkumar Kejriwal
- Jai Shishir Diwanji
What is the registered address of Alembic Pharmaceuticals Limited?
The registered address of Alembic Pharmaceuticals Limited is Alembic Road, Vadodara, Vadodara, Gujarat, India, 390003.
What is the Corporate Identification Number of Alembic Pharmaceuticals Limited?
The Corporate Identification Number of Alembic Pharmaceuticals Limited is L24230GJ2010PLC061123.